SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-003618
Filing Date
2017-02-10
Accepted
2017-02-10 19:23:00
Documents
1
Period of Report
2016-10-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12784
  Complete submission text file 0000899243-17-003618.txt   14120
Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 17595289

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)